| ［1］ |
Matsuda KM, Sharma D, Schonfeld AR, et al. Gabapentin and pregabalin for the treatment of chronic pruritus［J］. J Am Acad Dermatol, 2016,75（3）:619⁃625.e6. doi: 10.1016/j.jaad.2016.02. 1237.
|
| ［2］ |
Lam DM, Choi SW, Wong SS, et al. Efficacy of pregabalin in acute postoperative pain under different surgical categories: a Meta⁃analysis［J］. Medicine （Baltimore）, 2015,94（46）:e1944. doi: 10.1097/MD.0000000000001944.
|
| ［3］ |
Calandre EP, Rico⁃Villademoros F, Slim M. Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use［J］. Expert Rev Neurother, 2016,16（11）:1263⁃1277. doi: 10.1080/14737175. 2016.1202764.
|
| ［4］ |
Kukkar A, Bali A, Singh N, et al. Implications and mechanism of action of gabapentin in neuropathic pain［J］. Arch Pharm Res, 2013,36（3）:237⁃251. doi: 10.1007/s12272⁃013⁃0057⁃y.
|
| ［5］ |
Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia ［J］. N Engl J Med, 2014, 371（16）:1526⁃1533. doi: 10.1056/NEJMcp1403062.
|
| ［6］ |
Vargas⁃Espinosa ML, Sanmartí⁃García G, Vázquez⁃Delgado E, et al. Antiepileptic drugs for the treatment of neuropathic pain: a systematic review［J］. Med Oral Patol Oral Cir Bucal, 2012,17（5）:e786⁃e793.
|
| ［7］ |
Foroutan N, Nikvarz N. Role of pregabalin in management of pruritus: a literature review［J］. J Pharm Pharm Sci, 2016,19（4）:465⁃474. doi: 10.18433/J35K6N.
|
| ［8］ |
Asplund M, Calling S, Spirén A, et al. Prurigo nodularis⁃⁃pregabalin can be considered for more severe symptoms［J］. Lakartidningen, 2015,112. pii: DRFM.
|
| ［9］ |
Boyd ST, Mihm L, Causey NW. Improvement in psoriasis following treatment with gabapentin and pregabalin［J］. Am J Clin Dermatol, 2008,9（6）:419. doi: 10.2165/0128071⁃200809060⁃ 00012.
|
| ［10］ |
Remröd C, Sjöström K, Svensson Å. Pruritus in psoriasis: a study of personality traits, depression and anxiety［J］. Acta Derm Venereol, 2015,95（4）:439⁃443. doi: 10.2340/00015555⁃1975.
|
| ［11］ |
Szepietowski JC, Reich A. Pruritus in psoriasis: an update［J］. Eur J Pain, 2016,20（1）:41⁃46. doi: 10.1002/ejp.768.
|
| ［12］ |
Kuypers DR. Skin problems in chronic kidney disease［J］. Nat Clin Pract Nephrol, 2009,5（3）:157⁃170. doi: 10.1038/ncpneph 1040.
|
| ［13］ |
Mettang T, Kremer AE. Uremic pruritus［J］. Kidney Int, 2015,87（4）:685⁃691. doi: 10.1038/ki.2013.454.
|
| ［14］ |
Simonsen E, Komenda P, Lerner B, et al. Treatment of uremic pruritus: a systematic review［J］. Am J Kidney Dis, 2017,70（5）:638⁃655. doi: 10.1053/j.ajkd.2017.05.018.
|
| ［15］ |
Foroutan N, Etminan A, Nikvarz N, et al. Comparison of pregabalin with doxepin in the management of uremic pruritus: a randomized single blind clinical trial［J］. Hemodial Int, 2017,21（1）:63⁃71. doi: 10.1111/hdi.12455.
|
| ［16］ |
Gupta MA, Pur DR, Vujcic B, et al. Use of antiepileptic mood stabilizers in dermatology［J］. Clin Dermatol, 2018,36（6）:756⁃764. doi: 10.1016/j.clindermatol.2018.08.005.
|
| ［17］ |
Ahuja RB, Gupta GK. A four arm, double blind, randomized and placebo controlled study of pregabalin in the management of post⁃burn pruritus［J］. Burns, 2013,39（1）:24⁃29. doi: 10.1016/j.burns.2012.09.016.
|
| ［18］ |
Yilmaz S, Ceyhan AM, Baysal Akkaya V. Brachioradial pruritus succesfully treated with gabapentin［J］. 2010,37（7）:662⁃665. doi: 10.1111/j.1346⁃8138.2010.00830.x.
|
| ［19］ |
Atış G, Bilir KB. Pregabalin treatment of three cases with brachioradial pruritus［J］. Dermatol Ther, 2017,30:e12459. doi: 10.1111/dth.12459.
|
| ［20］ |
Iqbal Z, Azmi S, Yadav R, et al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy［J］. Clin Ther, 2018,40（6）:828⁃849. doi: 10.1016/j.clinthera.2018.04.001.
|
| ［21］ |
Şavk E. Neurologic itch management［J］. Curr Probl Dermatol, 2016,50:116⁃123. doi: 10.1159/000446053.
|
| ［22］ |
Picardi A, Abeni D, Melchi CF, et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized［J］. Br J Dermatol, 2000,143（5）:983⁃991.
|
| ［23］ |
Tey HL, Wallengren J, Yosipovitch G. Psychosomatic factors in pruritus［J］.Clin Dermatol, 2013,31（1）:31⁃40. doi: 10.1016/j.clindermatol.2011.11.004.
|
| ［24］ |
Melvin CL, Carey TS, Goodman F, et al. Effectiveness of antiepileptic drugs for the treatment of bipolar disorder: findings from a systematic review［J］. J Psychiatr Pract, 2008,14 Suppl 1:9⁃14. doi: 10.1097/01.pra.0000333583.75741.8b.
|
| ［25］ |
Ettinger AB, Argoff CE. Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain［J］. Neurotherapeutics, 2007,4（1）:75⁃83. doi: 10.1016/j.nurt. 2006.10.003.
|
| ［26］ |
Misery L, Alexandre S, Dutray S, et al. Functional itch disorder or psychogenic pruritus: suggested diagnosis criteria from the French psychodermatology group［J］. Acta Derm Venereol, 2007,87（4）:341⁃344. doi: 10.2340/00015555⁃0266.
|
| ［27］ |
Altunay IK, Atis G, Esen K, et al. Impact of functional pruritus compared with mild psoriasis on quality of life: a cross⁃sectional questionnaire study in Turkey［J］. Am J Clin Dermatol, 2014,15（4）:365⁃370. doi: 10.1007/s40257⁃014⁃0075⁃7.
|
| ［28］ |
Park JM, Jwa SW, Song M, et al. Efficacy and safety of pregabalin for the treatment of chronic pruritus in Korea［J］. J Dermatol, 2012,39（9）:790⁃791. doi: 10.1111/j.1346⁃8138.2012. 01572.x.
|
| ［29］ |
Laniosz V, Wetter DA, Godar DA. Dermatologic manifestations of fibromyalgia［J］. Clin Rheumatol, 2014,33（7）:1009⁃1013. doi: 10.1007/s10067⁃014⁃2488⁃3.
|
| ［30］ |
Häuser W, Bernardy K, Uçeyler N, et al. Treatment of fibromyalgia syndrome with gabapentin and pregabalin⁃⁃a meta⁃analysis of randomized controlled trials［J］. Pain, 2009,145（1⁃2）:69⁃81. doi: 10.1016/j.pain.2009.05.014.
|
| ［31］ |
Liu Q, Chen H, Xi L, et al. A randomized, double⁃blind, placebo⁃controlled trial to evaluate the efficacy and safety of pregabalin for postherpetic neuralgia in a population of Chinese patients［J］. Pain Pract, 2017,17（1）:62⁃69. doi: 10.1111/papr. 12413.
|
| ［32］ |
Baldwin DS, den Boer JA, Lyndon G, et al. Efficacy and safety of pregabalin in generalised anxiety disorder: a critical review of the literature［J］. J Psychopharmacol, 2015,29（10）:1047⁃1060. doi: 10.1177/0269881115598411.
|
